- Home
- CNMD vs DYN Comparison
CNMD vs DYN Comparison
Compare CNMD & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNMD
- DYN
- Stock Information
- Founded
- CNMD 1970
- DYN 1984
- Country
- CNMD United States
- DYN United States
- Employees
- CNMD N/A
- DYN N/A
- Industry
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- DYN Medicinal Chemicals and Botanical Products
- Sector
- CNMD Health Care
- DYN Health Care
- Exchange
- CNMD Nasdaq
- DYN Nasdaq
- Market Cap
- CNMD 1.7B
- DYN 1.4B
- IPO Year
- CNMD 1987
- DYN 2020
- Fundamental
- Price
- CNMD $54.03
- DYN $13.36
- Analyst Decision
- CNMD Hold
- DYN Strong Buy
- Analyst Count
- CNMD 5
- DYN 15
- Target Price
- CNMD $59.80
- DYN $36.27
- AVG Volume (30 Days)
- CNMD 477.4K
- DYN 3.0M
- Earning Date
- CNMD 10-29-2025
- DYN 07-28-2025
- Dividend Yield
- CNMD 1.49%
- DYN N/A
- EPS Growth
- CNMD 12.82
- DYN N/A
- EPS
- CNMD 3.54
- DYN N/A
- Revenue
- CNMD $1,326,244,000.00
- DYN N/A
- Revenue This Year
- CNMD $6.73
- DYN N/A
- Revenue Next Year
- CNMD $5.45
- DYN N/A
- P/E Ratio
- CNMD $15.18
- DYN N/A
- Revenue Growth
- CNMD 3.94
- DYN N/A
- 52 Week Low
- CNMD $46.00
- DYN $6.36
- 52 Week High
- CNMD $78.19
- DYN $46.26
- Technical
- Relative Strength Index (RSI)
- CNMD 51.16
- DYN 76.05
- Support Level
- CNMD $53.18
- DYN $12.86
- Resistance Level
- CNMD $55.07
- DYN $14.18
- Average True Range (ATR)
- CNMD 1.46
- DYN 0.59
- MACD
- CNMD -0.03
- DYN 0.15
- Stochastic Oscillator
- CNMD 38.47
- DYN 89.04
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.